These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38163846)

  • 41. Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons.
    Guillot TS; Miller GW
    Mol Neurobiol; 2009 Apr; 39(2):149-70. PubMed ID: 19259829
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of rat brain vesicular monoamine transporter by chronic treatment with ovarian hormones.
    Rehavi M; Goldin M; Roz N; Weizman A
    Brain Res Mol Brain Res; 1998 Jun; 57(1):31-7. PubMed ID: 9630494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 9-Cyclopropylmethoxy-dihydrotetrabenazine and its stereoisomers as vesicular monoamine transporter-2 inhibitors.
    Wang W; Lin S; Du G; Bai X; Lu J; Ye L; Wang H; Zhang R; Tian J
    Future Med Chem; 2022 Jul; 14(13):991-1003. PubMed ID: 35638444
    [No Abstract]   [Full Text] [Related]  

  • 44. High-efficiency expression and characterization of the synaptic-vesicle monoamine transporter from baculovirus-infected insect cells.
    Sievert MK; Thiriot DS; Edwards RH; Ruoho AE
    Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):959-66. PubMed ID: 9480916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tetrabenazine inhibition of monoamine uptake and methamphetamine behavioral effects: locomotor activity, drug discrimination and self-administration.
    Meyer AC; Horton DB; Neugebauer NM; Wooters TE; Nickell JR; Dwoskin LP; Bardo MT
    Neuropharmacology; 2011 Sep; 61(4):849-56. PubMed ID: 21669212
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia.
    Dorfman BJ; Jimenez-Shahed J
    Expert Rev Neurother; 2021 Jan; 21(1):9-20. PubMed ID: 33174440
    [No Abstract]   [Full Text] [Related]  

  • 47. The molecular chaperone Hsc70 interacts with the vesicular monoamine transporter-2.
    Requena DF; Parra LA; Baust TB; Quiroz M; Leak RK; Garcia-Olivares J; Torres GE
    J Neurochem; 2009 Jul; 110(2):581-94. PubMed ID: 19457116
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decreased vesicular monoamine transporter type 2 availability in the striatum following chronic cocaine self-administration in nonhuman primates.
    Narendran R; Jedema HP; Lopresti BJ; Mason NS; Himes ML; Bradberry CW
    Biol Psychiatry; 2015 Mar; 77(5):488-92. PubMed ID: 25062684
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazine.
    Raffo A; Hancock K; Polito T; Xie Y; Andan G; Witkowski P; Hardy M; Barba P; Ferrara C; Maffei A; Freeby M; Goland R; Leibel RL; Sweet IR; Harris PE
    J Endocrinol; 2008 Jul; 198(1):41-9. PubMed ID: 18577569
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Apparent opposite effects of tetrabenazine and reserpine on the toxic effects of 1-methyl-4-phenylpyridinium or 6-hydroxydopamine on nigro-striatal dopaminergic neurons.
    Cleren C; Naudin B; Costentin J
    Brain Res; 2003 Nov; 989(2):187-95. PubMed ID: 14556940
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Valbenazine for the treatment of tardive dyskinesia.
    Barquero N
    Drugs Today (Barc); 2016 Dec; 52(12):665-672. PubMed ID: 28276538
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-terminus regulation of VMAT2 mediates methamphetamine-stimulated efflux.
    Torres B; Ruoho AE
    Neuroscience; 2014 Feb; 259():194-202. PubMed ID: 24321511
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vesicular monoamine transporter 2: role as a novel target for drug development.
    Zheng G; Dwoskin LP; Crooks PA
    AAPS J; 2006 Nov; 8(4):E682-92. PubMed ID: 17233532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduced vesicular monoamine transport disrupts serotonin signaling but does not cause serotonergic degeneration.
    Alter SP; Stout KA; Lohr KM; Taylor TN; Shepherd KR; Wang M; Guillot TS; Miller GW
    Exp Neurol; 2016 Jan; 275 Pt 1(Pt 1):17-24. PubMed ID: 26428905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules.
    Henry JP; Botton D; Sagne C; Isambert MF; Desnos C; Blanchard V; Raisman-Vozari R; Krejci E; Massoulie J; Gasnier B
    J Exp Biol; 1994 Nov; 196():251-62. PubMed ID: 7823026
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural insights into vesicular monoamine storage and drug interactions.
    Ye J; Chen H; Wang K; Wang Y; Ammerman A; Awasthi S; Xu J; Liu B; Li W
    Nature; 2024 May; 629(8010):235-243. PubMed ID: 38499039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Harnessing the trophic and modulatory potential of statins in a dopaminergic cell line.
    Schmitt M; Dehay B; Bezard E; Garcia-Ladona FJ
    Synapse; 2016 Mar; 70(3):71-86. PubMed ID: 26695835
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dopamine modulating drugs influence striatal (+)-[11C]DTBZ binding in rats: VMAT2 binding is sensitive to changes in vesicular dopamine concentration.
    Tong J; Wilson AA; Boileau I; Houle S; Kish SJ
    Synapse; 2008 Nov; 62(11):873-6. PubMed ID: 18720517
    [TBL] [Abstract][Full Text] [Related]  

  • 59. VMAT2 identified as a regulator of late-stage β-cell differentiation.
    Sakano D; Shiraki N; Kikawa K; Yamazoe T; Kataoka M; Umeda K; Araki K; Mao D; Matsumoto S; Nakagata N; Andersson O; Stainier D; Endo F; Kume K; Uesugi M; Kume S
    Nat Chem Biol; 2014 Feb; 10(2):141-8. PubMed ID: 24316738
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine.
    Lizarraga LE; Cholanians AB; Phan AV; Herndon JM; Lau SS; Monks TJ
    Toxicol Sci; 2015 Jan; 143(1):209-19. PubMed ID: 25370842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.